Marubi biotechnology extends smart manufacturing project timeline to 2027
Guangdong Marubi Biotechnology Co., Ltd. plans to extend the "Cosmetics Smart Manufacturing Factory Construction Project" completion date from December 2025 to December 2027. This decision aims to ensure efficient use of raised capital and adapt to current market conditions and the company's operational needs. The company's board believes this extension will avoid potential underutilization of new production lines if commissioned too early, given current sufficient production capacity.
The project initially secured 790,000,000.20 yuan in net proceeds from its IPO in 2019. As of June 30, 2025, 247,652,700.00 yuan has been invested in the smart manufacturing factory, out of a planned 250,263,500.00 yuan. The remaining unutilized funds for all projects total 254,820,700.00 yuan. The factory building construction is complete, with Marubi gradually advancing production line installations based on future business growth.
This deferral is not expected to affect Marubi’s ongoing operations or financial health. The company emphasizes that the nature, total investment, and implementing entity of the project remain unchanged. The strategy involves a phased approach to investment, allowing for the integration of advanced production technologies and equipment that align with evolving market demands, ultimately enhancing the project's competitiveness and profitability.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Guangdong Marubi Biotechnology publishes news
Free account required • Unsubscribe anytime